Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 2592 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

2020 Deloitte global healthcare outlook

By: MattB
Views: 1830

Value of Personalized Medicine

By: MattB
Views: 2315

Medication Therapy Management Part D Programs

By: MattB
Views: 2002

Engaging HCPs in Post-Covid-19 Era - Pre-defined Priorities for Pharma Affiliates

By: MattB
Views: 2414

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 5

By: MattB
Views: 2388

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 2

By: MattB
Views: 1848

Tuberculosis

By: iFuzzle11
Views: 1641

Biopharma Companies Join Forces to Fight COVID-19

By: docshare
Views: 1834

ANTIBIOTICOS

By: JRMS
Views: 1472

Taming big Pharma

By: MattB
Views: 1893

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z